⚕️ Full Prescribing Information

For complete safety information, warnings, and dosage guidelines:

View FDA Label (PDF) →

📋 Overview

Jardiance (empagliflozin) is an SGLT2 inhibitor that helps lower blood sugar by causing the kidneys to remove sugar through urine. It has proven cardiovascular benefits.

How It Works

Jardiance blocks SGLT2 proteins in the kidneys, causing excess glucose to be excreted in urine, lowering blood sugar levels and reducing cardiovascular strain.

✓ FDA Approved Uses

  • Improve blood sugar in type 2 diabetes
  • Reduce cardiovascular death in adults with type 2 diabetes and cardiovascular disease
  • Reduce risk of heart failure hospitalization

🧪 Required Lab Monitoring

Your healthcare provider will order these tests to monitor your treatment:

Hemoglobin A1C Test
Every 3 months until stable, then every 6 months
Kidney Function Test
Baseline and periodically
Lipid Panel (Cholesterol Test)
Baseline and annually

Need to book these tests?

Order Tests Online →

⚡ Common Side Effects

Contact your doctor if these persist or worsen:

🚨 Serious Side Effects

Seek immediate medical attention if you experience:

  • Ketoacidosis
  • Severe urinary tract infections
  • Fournier gangrene (rare flesh-eating infection)
  • Severe dehydration
  • Acute kidney injury

⚠️ Do Not Use If

  • Severe kidney disease
  • History of serious hypersensitivity reaction
  • On dialysis
  • Type 1 diabetes

📢 Important Warnings

  • Monitor for signs of ketoacidosis
  • Stay well hydrated
  • Seek care for genital infections
  • May cause low blood pressure

📚 Sources

Last Reviewed: April 2026